"The voice of oncology in Massachusetts."



latest drug updates

<< First  < Prev   1   2   3   Next >  Last >> 
  • October 20, 2021 1:30 PM | Katy Monaco (Administrator)

    The Department of Health and Human Services released the administration’s Comprehensive Plan for Addressing High Drug Prices in response to President Biden’s executive order that identified a lack of industry competition as a key driver of high drug prices. Read More.

  • October 01, 2021 1:00 PM | Katy Monaco (Administrator)

    G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.

  • October 01, 2021 6:30 AM | Katy Monaco (Administrator)

    Oncopeptides announces J-code J9247 for Pepaxto® (melphalan flufenamide) injection, 1mg. This J-code will be effective on October 1, 2021.

  • September 19, 2021 3:30 PM | Katy Monaco (Administrator)

    Novartis announced results of the final overall survival (OS) analysis of the Phase III MONALEESA-2 study, which evaluated Kisqali® (ribociclib) in combination with letrozole compared to placebo plus letrozole in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer with no prior systemic treatment for advanced disease. These data will be presented as a late-breaker oral presentation at the European Society for Medical Oncology (ESMO) Congress 2021 on September 19 (#LBA17).  Read More.

  • July 01, 2020 10:41 AM | Katy Monaco (Administrator)

    Effective July 1, 2020, the following code J9358 can be used to identify ENHERTU® (fam-trastuzumab deruxtecan-nxki) when billing across settings of care as noted in the CMS HCPCS Application Summaries and Coding Decisions.

  • July 01, 2020 8:00 AM | Katy Monaco (Administrator)

    Astellas announces the assignment of a product-specific, permanent J-code for PADCEV. The Centers for Medicare & Medicaid Services (CMS) released the July 2020 Quarterly Healthcare Common Procedural Coding System (HCPCS) File, which includes the designation of J9177 for PADCEV with the effective date of July 1, 2020. 

<< First  < Prev   1   2   3   Next >  Last >> 

Massachusetts Society of Clinical Oncologists ©2023

860 Winter Street, Waltham, MA, 02451
Tel: 781.434.7329  |  email: msco@mms.org

Powered by Wild Apricot Membership Software